MWNA
ETNB

Marshall Wace North America’s 89bio ETNB Stock Holding History

Marshall Wace North America’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,923
Closed -$377K – 1543
2021
Q1 		$377K Buy
+15,923
New +$368K ﹤0.01% 1269

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Marshall Wace North America's ETNB Position: Q2 2021 in Review

Marshall Wace North America sold out of 89bio (ETNB) in Q2 2021, closing a stake of 15,923 shares — an estimated $377K sold.

Marshall Wace North America first reported a position in ETNB in Q1 2021 and held it in 1 quarter. The position peaked at $377K in Q1 2021. 49 funds tracked by Wall St. Rank hold ETNB as of Q2 2021.

  • Marshall Wace North America reported no remaining 89bio position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 15,923 89bio shares in Q2 2021, an estimated $377K.
  • Marshall Wace North America first reported a position in 89bio in Q1 2021 and held it in 1 quarter.
  • Marshall Wace North America's 89bio position peaked at $377K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held 89bio as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.